Jeffrey Del - Jun 28, 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role: Chief Commercial Officer
Signature: /s/ Jeffrey Del Carmen
Stock symbol: CPRX
Transactions as of: Jun 28, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/30/2022, 05:00 PM
Previous filing: Feb 16, 2022
Next filing: Aug 22, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CPRX	Common stock, par value $0.001 per share	Options Exercise		+10K	+141.44%		17.1K	Jun 28, 2022	Direct	F1
transaction	CPRX	Common stock, par value $0.001 per share	Tax liability		-2.93K	-17.16%		14.1K	Jun 28, 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CPRX	Restricted Stock Units	Options Exercise	$0	-10K	-1.32%	$0.00	747K	Jun 28, 2022	Common Stock	10K		Direct	F1, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F2	Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
F3	Derivative securities vest in equal tranches, 1/3rd on June 23, 2021, 1/3rd on June 23, 2022, and 1/3rd on June 23, 2023.
F4	Shares of common stock will be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on June 28, 2022.